Phthalic Acid

Phthalic Acid

SCHEMBL632002

CC(C)(O)C(O)CO.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
ALOX15 P16050 2/20 0.50
MAPT P10636 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
KDM4E B2RXH2 3/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
AKR1C3 P42330 2/20 0.41
MYC P01106 2/20 0.40
NR4A1 P22736 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HMGB1 P09429 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28702832 0.79 FOLH1 (0.50) ALDH1A1ALOX15MAPTHDAC8CA12
SCHEMBL2218734 0.79 ALDH1A1 (0.44) ALDH1A1ALOX15MAPTHDAC8KDM4E
Phthalic Acid SCHEMBL6255327 0.79 ALDH1A1 (0.61) ALDH1A1ALOX15MAPTHDAC8KDM4E
Phthalic Acid SCHEMBL10937971 0.79 ALDH1A1 (0.61) ALDH1A1ALOX15MAPTHDAC8KDM4E
Phthalic Acid SCHEMBL28441584 0.79 ALDH1A1 (0.61) ALDH1A1ALOX15MAPTHDAC8KDM4E
Phthalic Acid SCHEMBL1244535 0.78 ALDH1A1 (0.74) ALDH1A1ALOX15MAPTHDAC8KDM4E
Bicarbonate SCHEMBL29012511 0.78 OR51E2 (0.38) ALDH1A1TDP1
Phthalic Acid SCHEMBL9417364 0.77 ALDH1A1 (0.64) ALDH1A1ALOX15MAPTHDAC8KDM4E
Phthalic Acid SCHEMBL120455 0.77 ALDH1A1 (0.64) ALDH1A1ALOX15MAPTHDAC8KDM4E
Phthalic Acid SCHEMBL28446205 0.77 ALDH1A1 (0.64) ALDH1A1ALOX15MAPTHDAC8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207456-B Latent acids and their use 巴斯夫欧洲公司 2021-05-04 CN disclosed
EP-3253735-B1 LATENT ACIDS AND THEIR USE BASF SE (DE) 2021-03-31 EP disclosed
US-10133175-B2 Photosensitive resin composition, cured product and method for producing same, method for producing resin pattern, cured film, liquid crystal display device, organic el display device, infrared cut filter, and solid-state imaging device FUJIFILM CORPORATION (JP) 2018-11-20 US disclosed
US-9994538-B2 Latent acids and their use BASF SE (DE) 2018-06-12 US disclosed
US-9964848-B2 Positive photosensitive resin composition and cured film forming method using the same FUJIFILM CORPORATION (JP) 2018-05-08 US disclosed
US-20180009775-A1 LATENT ACIDS AND THEIR USE BASF SE (DE) 2018-01-11 US disclosed
US-9599901-B2 Photosensitive resin composition, cured product and method for producing same, method for producing resin pattern, cured film, liquid crystal display device, organic el display device, infrared cut filter, and solid-state imaging device FUJIFILM CORPORATION (JP) 2017-03-21 US disclosed
EP-2420890-B1 Positive photosensitive resin composition, method for forming cured film and liquid crystal display device FUJIFILM CORP (JP) 2017-03-01 EP disclosed
EP-2613198-B1 PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORP (JP) 2016-12-28 EP disclosed
US-20160327865-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING RESIN PATTERN, CURED FILM, LIQUID CRYSTAL DISPLAY DEVICE, ORGANIC EL DISPLAY DEVICE, INFRARED CUT FILTER, AND SOLID-STATE IMAGING DEVICE FUJIFILM CORPORATION (JP) 2016-11-10 US disclosed
EP-2420890-A1 Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device Fujifilm Corporation (JP) 2012-02-22 EP disclosed
US-20110229661-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME C/O FUJIFILM CORPORATION (JP) 2011-09-22 US disclosed
US-20110177302-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM FROM THE SAME FUJIFILM CORPORATION (JP) 2011-07-21 US disclosed
EP-2261737-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM FROM THE SAME FUJIFILM Corporation (JP) 2010-12-15 EP disclosed
US-20100173246-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING CURED FILM USING THE SAME FUJIFILM CORPORATION (JP) 2010-07-08 US disclosed
EP-2196852-A1 POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, AND METHOD FOR FORMATION OF CURED FILM USING THE SAME Fujifilm Corporation (JP) 2010-06-16 EP disclosed
US-20100119973-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2010-05-13 US disclosed
EP-2154571-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM THEREFROM Fujifilm Corporation (JP) 2010-02-17 EP disclosed
EP-2130095-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME Fujifilm Corporation (JP) 2009-12-09 EP disclosed
WO-2008123563-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180009775-A1 LATENT ACIDS AND THEIR USE LTA, C1S, C9 ALDH1A1 217/4885ALOX15 461/4885MAPT 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.